VWWMG
AUPH icon

Vermillion & White Wealth Management Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Vermillion & White Wealth Management Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,000
Closed -$22.1K – 579
2025
Q3 		$22.1K Buy
2,000
+100
+5% +$1.09K 0.01% 247
2025
Q2 		$16.1K Hold
1,900
– – 0.01% 248
2025
Q1 		$15.3K Sell
1,900
-1,600
-46% -$13K 0.01% 232
2024
Q4 		$31.4K Buy
+3,500
New +$28.6K 0.02% 165
2024
Q1 		– Sell
-3,300
Closed -$29.7K – 347
2023
Q4 		$29.7K Buy
+3,300
New +$27.2K 0.03% 122

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Vermillion & White Wealth Management Group's AUPH Position: Q4 2025 in Review

Vermillion & White Wealth Management Group sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2025, closing a stake of 2,000 shares — an estimated $22.1K sold.

Vermillion & White Wealth Management Group first reported a position in AUPH in Q4 2023 and held it in 5 quarters. The position peaked at $31.4K in Q4 2024. 255 funds tracked by Wall St. Rank hold AUPH as of Q4 2025.

  • Vermillion & White Wealth Management Group reported no remaining Aurinia Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 2,000 Aurinia Pharmaceuticals shares in Q4 2025, an estimated $22.1K.
  • Vermillion & White Wealth Management Group first reported a position in Aurinia Pharmaceuticals in Q4 2023 and held it in 5 quarters.
  • Vermillion & White Wealth Management Group's Aurinia Pharmaceuticals position peaked at $31.4K in Q4 2024.
  • 255 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2025.

Based on Vermillion & White Wealth Management Group's 13F filing for Q4 2025, filed 18 Feb 2026.